The Prognostic Impact of the Revised IPSS Cytogenetic Scoring System for Patients with MDS Allows a Risk-Stratification for Patients with MDS-Derived Acute Myeloid Leukemia
暂无分享,去创建一个
G. Ehninger | M. Schaich | U. Platzbecker | B. Mohr | M. Wermke | M. Bornhäuser | M. Kramer | F. Stölzel